State Street’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.03B Sell
3,173,105
-193,478
-6% -$63.1M 0.04% 377
2025
Q1
$909M Sell
3,366,583
-56,294
-2% -$15.2M 0.04% 389
2024
Q4
$805M Sell
3,422,877
-45,438
-1% -$10.7M 0.03% 424
2024
Q3
$954M Sell
3,468,315
-66,521
-2% -$18.3M 0.04% 383
2024
Q2
$859M Buy
3,534,836
+343,463
+11% +$83.5M 0.04% 388
2024
Q1
$477M Buy
3,191,373
+72,821
+2% +$10.9M 0.02% 537
2023
Q4
$597M Buy
3,118,552
+219,039
+8% +$41.9M 0.03% 478
2023
Q3
$514M Buy
2,899,513
+7,266
+0.3% +$1.29M 0.03% 480
2023
Q2
$549M Buy
2,892,247
+37,366
+1% +$7.1M 0.03% 483
2023
Q1
$572M Buy
2,854,881
+68,339
+2% +$13.7M 0.03% 464
2022
Q4
$662M Sell
2,786,542
-8,943
-0.3% -$2.13M 0.04% 416
2022
Q3
$560M Sell
2,795,485
-193,374
-6% -$38.7M 0.04% 426
2022
Q2
$436M Buy
2,988,859
+79,369
+3% +$11.6M 0.03% 516
2022
Q1
$475M Buy
2,909,490
+59,101
+2% +$9.65M 0.02% 542
2021
Q4
$483M Buy
2,850,389
+49,564
+2% +$8.41M 0.02% 546
2021
Q3
$529M Buy
2,800,825
+15,887
+0.6% +$3M 0.03% 514
2021
Q2
$472M Buy
2,784,938
+154,082
+6% +$26.1M 0.02% 548
2021
Q1
$371M Sell
2,630,856
-173,848
-6% -$24.5M 0.02% 591
2020
Q4
$365M Buy
2,804,704
+12,552
+0.4% +$1.63M 0.02% 565
2020
Q3
$407M Buy
2,792,152
+4,506
+0.2% +$656K 0.03% 477
2020
Q2
$413M Sell
2,787,646
-196,495
-7% -$29.1M 0.03% 479
2020
Q1
$325M Buy
2,984,141
+85,603
+3% +$9.32M 0.03% 481
2019
Q4
$334M Sell
2,898,538
-102,619
-3% -$11.8M 0.02% 563
2019
Q3
$241M Buy
3,001,157
+108,000
+4% +$8.69M 0.02% 631
2019
Q2
$210M Buy
2,893,157
+144,663
+5% +$10.5M 0.02% 679
2019
Q1
$257M Buy
2,748,494
+343,759
+14% +$32.1M 0.02% 608
2018
Q4
$175M Buy
2,404,735
+17,161
+0.7% +$1.25M 0.02% 659
2018
Q3
$209M Buy
2,387,574
+137,332
+6% +$12M 0.02% 693
2018
Q2
$222M Buy
2,250,242
+118,425
+6% +$11.7M 0.02% 652
2018
Q1
$254M Buy
2,131,817
+129,428
+6% +$15.4M 0.02% 603
2017
Q4
$254M Sell
2,002,389
-40,932
-2% -$5.2M 0.02% 605
2017
Q3
$240M Buy
2,043,321
+106,170
+5% +$12.5M 0.02% 608
2017
Q2
$155M Sell
1,937,151
-229,081
-11% -$18.3M 0.01% 748
2017
Q1
$111M Sell
2,166,232
-195,766
-8% -$10M 0.01% 886
2016
Q4
$88.4M Buy
2,361,998
+28,822
+1% +$1.08M 0.01% 968
2016
Q3
$158M Buy
2,333,176
+137,672
+6% +$9.33M 0.02% 695
2016
Q2
$122M Buy
2,195,504
+258,984
+13% +$14.4M 0.01% 759
2016
Q1
$122M Buy
1,936,520
+262,783
+16% +$16.5M 0.01% 773
2015
Q4
$158M Buy
1,673,737
+126,382
+8% +$11.9M 0.02% 681
2015
Q3
$124M Buy
1,547,355
+81,342
+6% +$6.54M 0.01% 741
2015
Q2
$176M Buy
1,466,013
+305,414
+26% +$36.6M 0.02% 647
2015
Q1
$121M Buy
1,160,599
+89,989
+8% +$9.4M 0.01% 797
2014
Q4
$104M Sell
1,070,610
-38,220
-3% -$3.71M 0.01% 845
2014
Q3
$86.6M Buy
1,108,830
+39,479
+4% +$3.08M 0.01% 900
2014
Q2
$67.6M Sell
1,069,351
-357,034
-25% -$22.6M 0.01% 1066
2014
Q1
$95.8M Buy
1,426,385
+10,979
+0.8% +$737K 0.01% 880
2013
Q4
$91M Sell
1,415,406
-112,432
-7% -$7.23M 0.01% 889
2013
Q3
$97.8M Sell
1,527,838
-60,471
-4% -$3.87M 0.01% 828
2013
Q2
$49.3M Buy
+1,588,309
New +$49.3M 0.01% 1120